# Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease

Study · id `cardio:ct-nct01653600` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01653600](<https://clinicaltrials.gov/study/NCT01653600>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01653600

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 346 participants.

## Technical summary

Registry record NCT01653600. Randomized; no masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2014-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 346 participants (planned count; ClinicalTrials.gov record NCT01653600, source copy `cardio:ctgov-nct01653600-2012-07-31`, retrieved 2026-10-31)
- Start date: 2012-09 (registry gives no type) (ClinicalTrials.gov record NCT01653600, source copy `cardio:ctgov-nct01653600-2012-07-31`, retrieved 2026-10-31)
- Primary completion: 2014-08 (anticipated) (ClinicalTrials.gov record NCT01653600, source copy `cardio:ctgov-nct01653600-2012-07-31`, retrieved 2026-10-31)
- Completion: 2015-08 (anticipated) (ClinicalTrials.gov record NCT01653600, source copy `cardio:ctgov-nct01653600-2012-07-31`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT01653600, source copy `cardio:ctgov-nct01653600-2012-07-31`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01653600-2012-07-31`, retrieved 2026-10-31)

## The registry's words

- Brief title: Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease
- Acronym: SENS-FP-2
- Condition: Peripheral Arterial Disease
- Condition: Atherosclerosis
- Intervention (Device): S.M.A.R.T CONTROL Stent
- Intervention (Device): LifeStent
- Lead sponsor: Korea University Guro Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Korea University Guro Hospital (`cardio:org-korea-university-guro-hospital`)

## Provenance

Content hash: a32fbd72b5932ea121d91c3b9e14e406a3d8ef0a06884080cb20b51d672c836e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
